Biogen and Samsung Bioepis said that they plan to present new real-world data from the companies’ anti-TNF biosimilar portfolio, which includes Flixabi, an infliximab biosimilar, and Imraldi, an adalimumab biosimilar.The company plans to present the data, which provides further insight into the long-term safety and efficacy as well as patient experience with anti-TNF biosimilars, at the Un
Vuno said that it would develop DEPREDICT, an artificial intelligence software that can predict antidepressant efficacy for patients suffering from major depression disorder (MDD), jointly with Europe's leading neuroimaging companies and research institutes.DEPREDICT SW can predict the long-term treatment efficacy of antidepressants by artificially analyzing MRI after patients with MDD take th
The local pharmaceutical industry is expressing its distrust and displeasure with the government's moves to support the supply of ranitidine alternatives.The industry points out that the government's countermeasures, such as the quicker approval of Ranitidine alternatives, are lacking in reality at a time when the production of finished Ranitidine alternatives has hit a snag faced with the sho
Dong-A ST is voluntarily giving up its membership of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KPBMA), 66 years after joining the group.The company decided so to take responsibility for receiving a sentence in an illegal rebate case, industry sources said. The drugmaker revealed its intention to leave the association at a meeting of the KPBMA’s boardroom on Tuesday.
GSK said that it has applied to obtain an additional indication for Trelegy Ellipta, an asthma inhaler, to the U.S. Food and Drug Administration. The treatment received approval from the FDA to treat chronic obstructive pulmonary disease (COPD) in September 2017.The company said that the submission of the application is supported by the pivotal phase 3 CAPTAIN study, conducted in 2,436 adu
A lawmaker criticized the government’s naïve response to the nation’s low birthrate and called for more aggressive measures.Rep. Oh Jae-sae of the ruling Democratic Party of Korea said Monday the low birthrate was regarded as a serious social issue in Japan when the fertility rate fell below 1.43 and the number of newborns a year failed to reach 1 million.In Korea, the situation was wo
Korea University Medicine (KUM) said that it would develop and supply the Korean-model public healthcare service platform to the National Chamber of Innovative Healthcare of the Republic of Uzbekistan (NCIHRU).The agreement aims at supporting the development of the medical industry in both Korea and Uzbekistan and further enhancing the capacity of the health industry through the exchange o
Korea’s large pharmaceutical companies are expected to have yielded good earnings in the third quarter, analysts said. Local drugmakers will begin to announce their quarterly performances, starting from Samsung BioLogics on Wednesday this week.Yuhan Corp., which had unsatisfying earnings in the first quarter, will receive royalties from a licensing-out deal in the third quarter. Brokerages for
Jeil Pharmaceutical said that the Ministry of Food and Drug Safety has approved Lonsurf, colorectal cancer treatment developed by Taiho and licensed in by Jeil.Lonsurf is an oral anticancer drug that contains trifluorothymidine and tipiracil hydrochloride in Korea.With the approval, hospitals can now use Lonsurf to treat patients with metastatic colorectal cancer who have been treated
President Moon Jae-in has pledged to foster the bio-health industry as a major growth engine. Still, related government ministries are going in the opposite direction, neglecting locally developed incrementally modified drugs (IMD), a lawmaker said.“The revised bill for generic drug prices, which was announced in July, contains a clause that removes the price advantage for IMDs,” Rep. Oh Jae-s
ATGC, a local biopharmaceutical firm, said that the Ministry of Food and Drug Safety has approved its phase 1 and 2 clinical trial for ATGC-110, botulinum toxin (BTX) product."With the approval, it has become highly possible that our ATGC-110 will become the world's third pure botulinum toxin A, following Xeomin and Coretox," the company said. "ATGC-110 is a product made by purifying 150kDa pu
Nearly half of doctors have encountered difficulties with patients over the recent Ranitidine ban incident, a survey showed.Intermd, an online site for knowledge sharing among physicians, said it polled 1,021 physicians regarding the response against the Ranitidine ban from Oct. 2.The survey result came after the Ministry of Food and Drug Safety suspended the manufacturing and selling of 2
The Ministry of Food and Drug Safety ordered Medytox to recall and discard mandatorily some of the company’s Meditoxin (export name: Neuronox) products sold overseas due to poor quality.The ministry issued the order after some of the botulinum toxin (BTX) products failed the regulator’s quality test. Medytox has exported 3.3 billion won ($2.79 million) worth of defective items, the ministr
Daewoong Pharmaceutical said that it has launched its botulinum toxin (BTX) product, Nuceiva, in Canada. Nuceiva is also known as Jeuveau in the U.S. and Nabota in Korea.Evolus, Daewoong's exclusive partner for BTX, had obtained sales approval for Nuceiva from Health Canada in August last year.Canada is a member country of seven major developed countries (G7) and the fifth member to jo
Despite the government’s anti-tuberculosis efforts, Korea still suffered the highest TB incidence and mortality among the members of the Organization for Economic Cooperation and Development in 2018. In the nation, 72 people were newly infected with TB, and five people died due to the disease every day last year.Rep. Nam In-soon of the ruling Democratic Party released the data from the Korea C
The rise of artificial intelligence (AI) has thrown pharmaceutical companies and medical device into a race to develop new products and services to open the age of AI healthcare.Korea also has been approving, slowly but steadily, new AI medical devices for use in the clinical field while setting up new regulations and application methods to speed up the new sector’s development. Not all AI
The Financial Services Commission (FSC) issued a warning on retail investors, saying they should be aware of investment risks in local biotech and pharmaceutical stocks.The FSC announced the “Notes on investing into biotech and pharmaceutical shares” on Thursday.“Biotech and pharmaceutical shares have uncertainties about success in the development and approval of medicines that require muc
CHA Biotech said it has registered a patent for the method of manufacturing and storing somatic cloned embryonic stem cells in Korea.The patent, jointly developed by CHA Biotech and Cha Medical University, uses somatic cell nuclear transfer cloning technology to generate embryonic stem cells with low immune rejection and stores them.Embryonic stem cells have better proliferation and differ
Researchers at Severance Hospital have discovered RORα, a new gene that can inhibit the inflammatory mechanism in intestines.The team, led by Professor Hwang Seong-soon at the hospital, removed the RORα gene from the intestinal epithelial cells of rats and induced an intestinal inflammatory response. As a result, rats with RORα gene deficiency not only had a more severe inflammatory respon
Digital therapeutics can be classified as medicine and non-medicine at the same time. People regard a drug as a product made from synthetic or natural ingredients, taken orally, or injected. A dictionary defines medicine as “a substance used in treating or preventing diseases or wounds, taken orally or applied or injected.” Digital therapeutics, however, disrupt this “common sense.” They refer